Top in cardiology: Caregiver support linked to better CV health; rate in CV deaths slows
Click Here to Manage Email Alerts
A study recently showed that adults who experienced abuse or neglect from caretakers were less likely to have ideal cardiovascular health.
Researchers analyzed data from the CARDIA study, which included CV health evaluations up to 20 years after enrollment. The longitudinal study determined that for each unit increase in Risky Family Environment score, the odds of achieving high CV health decreased by 3.6%.
“Our study results offer cutting-edge insight into how policies, practices and programming that support healthy, supportive and consistent caregiver and child relationships, and perhaps more simply, healthy and resourced adults who may be caregivers of children, may offset risk for the No. 1 killer of Americans — CVD — and enhance overall health,” Robin Ortiz, MD, MS, FAAP, DipABLM, assistant professor of pediatric and public health and a core faculty member in the Institute for Excellence in Health Equity at New York University Grossman School of Medicine, told Healio.
It was the top story in cardiology last week.
In another top story, the number of CV-related deaths increased by less than 3,000 from 2020 to 2021, a modest increase compared to 2019 to 2020 (more than 50,000). However, experts are still concerned about the upward trend and have stressed the need for public education about CVD.
Read these and more top stories in cardiology below:
Childhood adversity, caregiver warmth tied to long-term heart health
Adults who reported experiences of childhood adversity such as abuse or neglect were less likely to have optimal CV health at various points during 20 years of follow-up, underscoring the impact of positive caregiver-child relationships. Read more.
AHA: Slowdown in CV deaths after pandemic, but troubling trends persist
New data from the American Heart Association show the overall number of CV-related deaths again rose year over year from 2020 to 2021, though the increase was far smaller than what was observed the previous year. Read more.
New CLEAR Outcomes data: Bempedoic acid cuts risk for recurrent CV events
A prespecified analysis of the CLEAR Outcomes trial shows that the benefits of bempedoic acid extend to patients with recurrent CV events, including a total reduction in MI risk of 31% vs. placebo. Read more.
High Lp(a) common in patients undergoing CABG; linked to poor outcomes
High lipoprotein(a), a relatively common finding in patients undergoing CABG, was associated with increased risk for all-cause death after surgery, researchers reported. Read more.
‘EyePhone’ app evaluates eye movement to detect vestibular strokes
A novel smartphone app was shown to diagnose vestibular stroke symptoms via tracked eye movements in healthy volunteers with an accuracy similar to current clinical standard devices, researchers reported. Read more.